---
title: "Stock Market Today: August 24, 2021"
description: The U.S. stock market logged a solid advance yesterday, with notable strength in the technology and energy names. The mood on Wall Street seemed quite optimistic, despite the ongoing challenges caused by the coronavirus pandemic. Looking to the day ahead, the equity futures all point higher, indicating a favorable start to today’s session.
image: https://investor.valueline.com/hubfs/social-suggested-images/iStock_000006488152XSmall-431.jpg
---

[![The Value Line Blog](https://investor.valueline.com/hubfs/VL%20Blog%20Images/vl_blog_header.png)](https://investor.valueline.com/blog)

[Stock Market Today](https://investor.valueline.com/blog/topic/stock-market-today)

# Stock Market Today: August 24, 2021

 August 24, 2021

### **Before The Bell**

The U.S. stock market logged a solid advance yesterday, with notable strength in the technology and energy names. The mood on Wall Street seemed quite optimistic, despite the ongoing challenges caused by the coronavirus pandemic. On a related note, in the United States, the Pfizer ([PFE](https://research.valueline.com/research#sec=company&sym=PFE)) vaccine received full FDA approval yesterday, a development that could lead to higher vaccination rates. Overnight, the international markets have been trading in a mixed fashion. In Asia, the Nikkei advanced nicely. In Europe, the FTSE 100 has been putting in a weak performance. On our shores, the equity futures all point higher, indicating a favorable start to today’s session.

In economic news, just one notable report will be issued today. Specifically, this morning we will get a look at the new home sales figures for the month of July. This item follows the favorable existing home sales numbers that were delivered yesterday. Investors will likely want to see continued strength in the housing market, as the real estate sector plays an important role in the general economy. Later this week, the central bank will hold a virtual version of its annual Jackson Hole Economic Policy Symposium. Traders will be closely watching the proceedings, and analyzing the remarks being offered, as they look for potential shifts in monetary policy. The Federal Reserve has indicated that it plans to gradually reduce its asset purchase program as the economy strengthens. However, the timing and magnitude of any moves remains uncertain. Of note, the low interest-rate environment has been a major support to the economy and the stock market. The yield on the 10-year Treasury is currently at around 1.25%, which is quite low, and provides support for equities, particularly dividend paying issues.

In the corporate arena, we continue to receive reports from companies that follow non-calendar fiscal years. After the market closed yesterday, we heard from Palo Alto Networks ([PANW](https://research.valueline.com/research#list=recent&sec=company&sym=panw)), a provider of cyber-security solutions. Investors were pleased with that company’s progress, and the stock is moving higher pre-market trading. This morning, medical device maker Medtronic ([MDT](https://research.valueline.com/research#list=recent&sec=company&sym=mdt)) weighed in with solid numbers. In addition, electronics retailer Best Buy ([BBY](https://research.valueline.com/research#list=recent&sec=company&sym=bby)) delivered a solid issuance and provided an upbeat outlook.

Technically, the stock market continues to display resilience. Just a few days ago, the S&P 500 Index pulled back to its 50-day moving average (located around the 4,360 level). However, the averages managed to find support at this key area, and have since recovered. From here, it remains to be seen if the bulls can mount a sustained buying campaign and drive equities higher.

– Adam Rosner

*At the time of this article’s writing, the author did not have positions in any of the companies mentioned.*

[![Register now for our free One Stock to Buy webinar](https://no-cache.hubspot.com/cta/default/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5.png)](https://cta-redirect.hubspot.com/cta/redirect/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5)

### Popular Posts

Search

Search Blog

### Topics

- [Investing 101 (2)](https://investor.valueline.com/blog/topic/investing-101)
- [Market Commentary (37)](https://investor.valueline.com/blog/topic/market-commentary)
- [Stock Highlights (390)](https://investor.valueline.com/blog/topic/stock-highlights)
- [Stock Market Today (2071)](https://investor.valueline.com/blog/topic/stock-market-today)

 Copyright 2026 Value Line, Inc. All Rights Reserved. Factual material is obtained from sources believed to be reliable and is provided without warranties of any kind. VALUE LINE IS NOT RESPONSIBLE FOR ANY ERRORS OR OMISSIONS HEREIN OR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. This blog is strictly for subscriber's own, non-commercial, internal use. No part of it may be reproduced, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product. Officers, directors, or employees of Value Line, Inc. and its affiliates and subsidiaries, and EULAV Asset Management, may own stocks that are featured in this email. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice. Value Line, the Value Line logo, The Most Trusted Name in Investment Research, “Smart research. Smarter investing.”, The Value Line Investment Survey, Timeliness, and Safety are trademarks or registered trademarks of Value Line, Inc. and/or its affiliates in the United States and other countries.